{"schema_version":"1","generated_at":"2026-11-09T19:44:43.028Z","data_as_of":"2026-11-09","url":"https://www.findmykol.com/kol/yakup-ergun","json_url":"https://www.findmykol.com/kol/yakup-ergun/profile.json","record_kind":"full","profile_kind":"professional","person":{"slug":"yakup-ergun","name":"Yakup Ergün","title":"Medical Oncology","therapeutic_area":"Gastrointestinal","therapeutic_areas":["Gastrointestinal","Breast"],"institution":"Bower Hospital","institution_url":"https://www.findmykol.com/institution/bower-hospital"},"identifiers":{"orcid":"0000-0003-4784-6743","openalex":"A5041705584"},"summary":"Yakup Ergün: Medical Oncology at Bower Hospital. OpenAlex indexes 118 publications with 551 citations (h-index 11).","overview":{"text":"Yakup Ergün is Medical Oncologist at Bower Hospital. The public record shows 118 publications with 551 citations (h-index 11), centered on Colorectal Cancer Treatments and Studies, Breast Cancer Treatment Studies, Gastric Cancer Management and Outcomes.","bullets":["Most recent indexed publication: 2026 · Journal of the National Cancer Institute","Top research focus: Colorectal Cancer Treatments and Studies"],"generated_at":"2026-11-09"},"focus":{"indications":[{"label":"Bladder / Urothelial Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Breast Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Colorectal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"COVID-19","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Gastroesophageal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Head & Neck Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Hepatobiliary Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Lymphoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Melanoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Ovarian / Gynecologic Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Pancreatic Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Kidney Cancer / RCC","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Thyroid Disorders","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Viral Hepatitis (B/C)","therapeutic_area":"Gastroenterology","trials":0,"topics":0,"strength":1}],"research_topics":["Colorectal Cancer Treatments and Studies","Breast Cancer Treatment Studies","Gastric Cancer Management and Outcomes","Cancer Immunotherapy and Biomarkers","Colorectal Cancer Surgical Treatments"]},"scholarship":{"works_count":118,"cited_by_count":551,"h_index":11,"i10_index":15,"pubmed_count":32,"latest_activity_year":2026,"source":"works"},"trials":{"shown":0,"withheld":0,"rows":[],"source":"trials"},"payments":{"note":"Not attributed. This person has no U.S. clinical registration (NPI) on file, so industry payments cannot be reliably tied to them."},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":11,"years":{"first":2019,"last":2025},"societies":["ASCO","ESMO"],"shown":3,"withheld":8,"rows":[{"title":"Efficacy of anti-VEGF & anti-EGFRs in microsatellite instable (MSI-H) metastatic colorectal cancer, Turkish Oncology Group (TOG) study.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.e15507","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.e15507","status":"verified"},{"title":"456eP Comparison of the pathological complete response to neoadjuvant therapy between immunohistochemistry HER2 (3+) and HER2 (2+)/ISH+ early stage breast cancer: A systemic review and meta-analysis","society":"ESMO","meeting":"ESMO Congress","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1016/j.annonc.2025.08.879","source_url":"https://doi.org/10.1016/j.annonc.2025.08.879","status":"verified"},{"title":"443P Efficacy and safety of CDK 4/6 inhibitors in patients with bone marrow-involved metastatic breast cancer","society":"ESMO","meeting":"ESMO Congress","year":2023,"role":"co_author","presentation_type":"poster","contribution_type":"abstract","doi":"https://doi.org/10.1016/j.annonc.2023.09.619","source_url":"https://doi.org/10.1016/j.annonc.2023.09.619","status":"verified"}],"source":"congress"},"publications":{"total":32,"shown":5,"withheld":27,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"RE: Endocrine Therapy in Early-stage Estrogen Receptor-Low Breast Cancer: A Systematic Review and Meta-Analysis.","year":2026,"journal":"Journal of the National Cancer Institute","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42920273/","status":"verified"},{"title":"Association Between ABO Blood Group and Survival Outcomes in Advanced NSCLC Treated with Immune Checkpoint Inhibitors.","year":2026,"journal":"Current oncology (Toronto, Ont.)","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42930157/","status":"verified"},{"title":"Comparative Safety Profiles of Sacituzumab Govitecan and Datopotamab Deruxtecan: A Real-World Pharmacovigilance Study.","year":2026,"journal":"Journal of clinical medicine","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42881867/","status":"verified"},{"title":"Efficacy and safety of omitting 5-fluorouracil bolus in combination chemotherapy regimens for gastrointestinal cancers: a systematic review and meta-analysis.","year":2026,"journal":"Expert opinion on drug safety","types":["Systematic Review","Journal Article","Meta-Analysis"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40590359/","status":"verified"},{"title":"Genomic divergence between matched primary and metastatic tumors across cancer types: a pan-cancer analysis of 5,692 samples.","year":2026,"journal":"Expert review of anticancer therapy","types":["Journal Article","Comparative Study"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41354463/","status":"verified"}],"most_cited":{"total":118,"shown":5,"withheld":113,"rows":[{"title":"Comparison of HER2-zero and HER2-low in terms of clinicopathological factors and survival in early-stage breast cancer: A systematic review and meta-analysis","year":2023,"cited_by_count":65,"type":"review","source_url":"https://doi.org/10.1016/j.ctrv.2023.102538"},{"title":"Immunogenicity and Safety of the Coronavac Vaccine in Patients with Cancer Receiving Active Systemic Therapy","year":2021,"cited_by_count":39,"type":"article","source_url":"https://doi.org/10.2217/fon-2021-0597"},{"title":"Correlation between peripheral blood inflammatory indicators and pathologic complete response to neoadjuvant chemotherapy in locally advanced breast cancer patients","year":2020,"cited_by_count":25,"type":"article","source_url":"https://doi.org/10.1097/md.0000000000020346"},{"title":"The prognostic value of the prognostic nutritional index in patients with metastatic colorectal cancer","year":2020,"cited_by_count":24,"type":"article","source_url":"https://doi.org/10.1111/ajco.13328"},{"title":"Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer","year":2020,"cited_by_count":24,"type":"article","source_url":"https://doi.org/10.1097/md.0000000000022407"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Gökhan Uçar","coauthored_works":41},{"name":"Doğan Uncu","coauthored_works":33,"profile_url":"https://www.findmykol.com/kol/dogan-uncu"},{"name":"Yusuf Açıkgöz","coauthored_works":28}],"source":"works"},"similar":[{"name":"Eric Van Cutsem","slug":"eric-cutsem","institution":"University Hospitals Leuven (UZ Leuven)","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/eric-cutsem","json_url":"https://www.findmykol.com/kol/eric-cutsem/profile.json"},{"name":"Josep Tabernero","slug":"josep-tabernero","institution":"Vall d'Hebron Institute of Oncology (VHIO)","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/josep-tabernero","json_url":"https://www.findmykol.com/kol/josep-tabernero/profile.json"},{"name":"Jaffer Ajani","slug":"jaffer-ajani","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jaffer-ajani","json_url":"https://www.findmykol.com/kol/jaffer-ajani/profile.json"},{"name":"Charles Fuchs","slug":"charles-fuchs","institution":"Tubulis GmbH","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/charles-fuchs","json_url":"https://www.findmykol.com/kol/charles-fuchs/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"congress":8,"publications":27,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-09"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-09"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-09"},"professional_identity":{"label":"Official professional record","url":"https://bowerhospital.com/tr/doktor/yakup-ergun","verified_at":"2026-11-08 04:08:06.367486+00"}},"methodology_url":"https://www.findmykol.com/about#methodology"}